ダウンロード数: 235

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
12_501.pdf693.79 kBAdobe PDF見る/開く
タイトル: 泌尿器科領域における「フルクトンM」の治験例
その他のタイトル: Clinical use of "fuructone" as postoperative intravenous fluid
著者: 稲田, 務  KAKEN_name
酒徳, 治三郎  KAKEN_name
沢西, 謙次  KAKEN_name
相馬, 隆臣  KAKEN_name
川村, 寿一  KAKEN_name
三宅, ヨシマル  KAKEN_name
著者名の別形: INADA, Tsutomu
SAKATOKU, Jisaburo
SAWANISHI, Kenji
SOHMA, Takaomi
KAWAMURA, Juichi
MIYAKE, Yoshimaru
キーワード: Adult
Female
Fructose/therapeutic use
Humans
Injections, Intravenous
Kidney Failure, Acute/prevention & control
Male
Mannitol/therapeutic use
Middle Aged
Postoperative Complications/prevention & control
発行日: May-1966
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 12
号: 5
開始ページ: 501
終了ページ: 510
抄録: Furucton M was intravenously administered to 21 postoperative in -patients , 300 ml per day for 3 days following operation, mixed with other intravenous fluids. Before and after its administration, urinary volume, specific gravity and osmolarity of urine and its diuretic effects were examined, as well as alterations of blood pressure, serum total protein, serum non-protein nitrogen, serum creatinine, serum osmolarity and serum electrolytes and changes in general condition, especially influences on renal and liver functions. The results are described and discussed here. In cases with good renal function, the treatment contributed to diuretic effects and protective action to postoperative renal dysfunction. However, in cases with poor renal function, a warning was evident that the administration must be performed with a care for development of imbalance of serum electrolytes, especially hyponatremia. Recent knowledges were introduced about the mechanism of o smotic diuresis of mannitol and clinical reevaluation of fructose from the energic metabolic point of view.
URI: http://hdl.handle.net/2433/112951
PubMed ID: 6006793
出現コレクション:Vol.12 No.5

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。